Nordson(US:NDSN)2025-12-10 21:34Financial Performance - Fourth quarter sales were $752 million, a 1% increase from $744 million in the prior year[1] - Net income for the fourth quarter was $152 million, or $2.69 per diluted share, compared to $122 million, or $2.12 per diluted share in the prior year[2] - Adjusted earnings per diluted share increased by 9% to $3.03 from $2.78 in the prior year[2] - Full year sales reached a record $2.8 billion, a 4% increase compared to the previous year[9] - Full year adjusted earnings per diluted share were $10.24, a 5% increase from $9.73 in the prior year[10] - EBITDA for the fourth quarter was $256 million, representing 34% of sales, up from $241 million or 32% of sales in the prior year[3] - Net income for the twelve months ended October 31, 2025, was $484,474, an increase of 3.5% compared to $467,284 for the same period in 2024[26] - Total sales for the twelve months ended October 31, 2025, reached $2,791,687, representing a 3.8% increase from $2,689,921 in 2024[28] - The company reported a diluted earnings per share of $8.51 for the twelve months ended October 31, 2025, compared to $8.11 in 2024, marking a 4.9% increase[32] Segment Performance - The Industrial Precision Solutions segment saw a 2% decrease in sales to $362 million, while Medical and Fluid Solutions increased by 10% to $220 million[5][6] - The Medical and fluid solutions segment saw a sales increase of 20.1% for the twelve months ended October 31, 2025, reaching $835,385 compared to $695,452 in 2024[28] - The company experienced a total sales decline of 1.1% in the three months ended October 31, 2025, compared to the same period in 2024[28] Cash Flow and Investments - The company achieved a free cash flow conversion rate of 136% of net income, totaling $661 million for the full year[11] - Cash flows from operating activities for the twelve months ended October 31, 2025, were $719,175, up from $556,193 in 2024, indicating a 29.2% increase[26] - Year-to-date net cash provided by operating activities increased to $719,175,000 compared to $516,264,000 in the previous year[34] - Year-to-date free cash flow reached $661,115,000, up from $467,262,000 year-over-year[34] - Quarter-to-date free cash flow was reported at $193,853,000[34] - Net cash used in investing activities for the twelve months ended October 31, 2025, was $(26,690), significantly improved from $(844,398) in 2024[26] - Additions to property, plant, and equipment year-to-date totaled $58,060,000, compared to $49,002,000 in the previous year[34] Future Outlook - The company expects fiscal 2026 sales to range between $2,830 million and $2,950 million, with adjusted earnings forecasted between $10.80 and $11.50 per diluted share[14] - The backlog for fiscal 2026 is approximately $600 million, a 5% increase from the prior year[13] Balance Sheet Highlights - Total current assets decreased to $1,242,851 as of October 31, 2025, down from $1,275,032 in 2024, reflecting a decline of 2.5%[24] - Long-term debt decreased to $1,681,254 as of October 31, 2025, down from $2,101,197 in 2024, a reduction of 20%[24] - Total shareholders' equity increased to $3,043,571 as of October 31, 2025, compared to $2,932,192 in 2024, reflecting a growth of 3.8%[24] Non-GAAP Measures - The company emphasizes the importance of non-GAAP measures for evaluating ongoing operations and future forecasts[34] - Management believes non-GAAP measures are useful for investors to assess changes in the company's core business over time[34]